NASHUA, N.H., May 13 /PRNewswire-FirstCall/ -- iCAD, Inc. , an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that Anthony F. Ecock, a Senior Operating Executive with the private equity firm, Welsh, Carson, Anderson & Stowe, and former Vice President and General Manager of GE Healthcare has been appointed to the Company’s Board of Directors, increasing the number of directors to eight. Mr. Ecock, age 46, brings more than nine years of healthcare technology experience and more than 15 years of senior management experience at companies including GE Healthcare and Hewlett Packard to iCAD.
“We are extremely pleased to have Tony Ecock join our Board,” said Ken Ferry, Chief Executive Officer of iCAD, Inc. “Tony’s impressive track record managing healthcare technology companies as well as his extensive global business experience will be of tremendous value to our Company worldwide.”
“I am delighted to join iCAD at this time of rapid growth for the Company. With the ongoing transition to digital mammography and iCAD’s leading computer aided detection software, the Company is poised for continued global growth and expansion,” said Tony Ecock.
Mr. Ecock currently serves as Senior Operating Executive with the private equity firm, Welsh, Carson, Anderson & Stowe (“WCAS”) where he is responsible for helping portfolio companies identify and implement growth and EBITDA improvement opportunities. Prior to joining WCAS, Ecock was the Vice President and General Manager of GE Healthcare’s Enterprise Sales organization from 2003 until 2007. From 1999 to 2003 he was Senior Vice President and Global General Manager of Hewlett Packard’s Patient Monitoring Division, their largest healthcare division, which was acquired by Philips. Ecock spent the early part of his career with the consulting firm Bain & Company, where he was a Partner, Practice Leader for Information Technology and Program Director for Consultant Training. Mr. Ecock received his Bachelor of Science in Economics from The Wharton School of the University of Pennsylvania and his M.B.A. from Harvard Business School.
About iCAD, Inc.
iCAD, Inc. is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by more than 2,000 women’s healthcare centers worldwide. For more information, call +1 877 iCADnow or visit www.icadmed.com.
For iCAD, contact Darlene Deptula-Hicks at 603-882-5200 x7944, or via email at
CONTACT: Darlene Deptula-Hicks of iCAD, Inc., +1-603-882-5200, ext. 7944,
ddeptula@icadmed.com; or Investor Relations, Anne Marie Fields of
Lippert-Heilshorn & Associates, +1-212-838-3777, ext. 6604, icad@lhai.com,
or Public Relations, Jill Testagrossa of Schwartz Communications,
+1-781-684-0770, icad@schwartz-pr.com, both for iCAD, Inc.
Web site: http://www.icadmed.com/
